Literature DB >> 24131800

Posterior reversible encephalopathy syndrome in systemic lupus erythematosus following methylprednisolone: report of two cases.

Srinivasa Chennareddy1, Ramakrishnam Adapa, Babu K V Kishore, Liza Rajasekhar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24131800     DOI: 10.1111/1756-185X.12148

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


× No keyword cloud information.
  6 in total

1.  The spectrum of posterior reversible encephalopathy in systemic lupus erythematosus.

Authors:  Amritha Budhoo; Girish M Mody
Journal:  Clin Rheumatol       Date:  2015-08-23       Impact factor: 2.980

2.  Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome.

Authors:  Neal S Parikh; Andrew D Schweitzer; Robert J Young; Ashley E Giambrone; John Lyo; Sasan Karimi; Anna Knobel; Ajay Gupta; Babak B Navi
Journal:  J Neurol Sci       Date:  2017-06-29       Impact factor: 3.181

3.  Posterior reversible encephalopathy syndrome (PRES) attributed to mycophenolate mofetil during the management of SLE: a case report and review.

Authors:  Lei Zhang; Jian Xu
Journal:  Am J Clin Exp Immunol       Date:  2018-02-05

4.  Posterior reversible encephalopathy syndrome in children: a case series.

Authors:  Serhat Emeksiz; Nurettin Onur Kutlu; Hüseyin Çaksen; Gülsüm Alkan; Hülya Şeker Yıkmaz; Hüseyin Tokgöz
Journal:  Turk Pediatri Ars       Date:  2016-12-01

5.  Posterior Reversible Encephalopathy Syndrome Resolving Within 48 Hours in a Normotensive Patient Who Underwent Thoracic Spine Surgery.

Authors:  Kunal Vakharia; Ioannis Siasios; Vassilios G Dimopoulos; John Pollina
Journal:  J Clin Med Res       Date:  2016-01-26

6.  Clinical features, outcome, and associated factors for posterior reversible encephalopathy in Thai patients with systemic lupus erythematosus: a case-control study.

Authors:  Usanee Damrongpipatkul; Kanokporn Oranratanachai; Nuntana Kasitanon; Salita Wuttiplakorn; Worawit Louthrenoo
Journal:  Clin Rheumatol       Date:  2017-11-04       Impact factor: 3.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.